Virtu Financial’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-250
| Closed | -$41K | – | 1683 |
|
|
2023
Q4 | $41K | Buy |
+250
| New | +$41K | ﹤0.01% | 1208 |
|
|
2023
Q2 | – | Sell |
-54
| Closed | -$42K | – | 1713 |
|
|
2023
Q1 | $42K | Buy |
54
+33
| +157% | +$25.7K | ﹤0.01% | 1126 |
|
|
2022
Q4 | $6K | Sell |
21
-47
| -69% | -$13.4K | ﹤0.01% | 1432 |
|
|
2022
Q3 | $34K | Buy |
68
+45
| +196% | +$22.5K | ﹤0.01% | 1287 |
|
|
2022
Q2 | $13K | Buy |
+23
| New | +$13K | ﹤0.01% | 1399 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | -$57K | – | 1709 |
|
|
2021
Q4 | $57K | Buy |
+50
| New | +$57K | 0.01% | 1309 |
|
|
2021
Q3 | – | Sell |
-114
| Closed | -$225K | – | 1686 |
|
|
2021
Q2 | $225K | Sell |
114
-65
| -36% | -$128K | 0.02% | 914 |
|
|
2021
Q1 | $329K | Buy |
+179
| New | +$329K | 0.02% | 763 |
|
|
2019
Q4 | $79K | Sell |
15
-3
| -17% | -$15.8K | 0.01% | 1127 |
|
|
2019
Q3 | $44K | Sell |
18
-16
| -47% | -$39.1K | ﹤0.01% | 1217 |
|
|
2019
Q2 | $140K | Buy |
+34
| New | +$140K | 0.01% | 1061 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | -$16K | – | 1351 |
|
|
2018
Q4 | $16K | Buy |
+1
| New | +$16K | ﹤0.01% | 1388 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1450 |
|
|
2018
Q2 | – | Hold |
0
| – | -$2K | – | 2192 |
|
|
2018
Q1 | – | Hold |
0
| – | -$65K | – | 1873 |
|
|
2017
Q4 | – | Hold |
0
| – | -$17K | – | 2022 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 2366 |
|